INBRE Collaborative Projects
A Predictive Modeling Framework for Studying Disparity in Colorectal Screening
Summary:
This proposal aims to develop a colorectal cancer data repository by engaging participation
                                 from the Louisiana Clinical Data Research Network (LACDRN) from a regionally distributed
                                 population, and developing a predictive model by identifying the underlying key factors
                                 that are highly correlated with the gender and race. The proposed predictive model
                                 will then aid in computing the confidence associated with each patient on the risk
                                 of developing colon cancer. The results generated from the proposed study will lead
                                 us to advance in closing the loop between the established factors of race and gender
                                 as being the covariates, along with other unidentified and underlying environmental
                                 and socio-economic factors from South Louisiana. 
Neurolymphatic Biomarker Analysis in Multiple Sclerosis
Summary:
Multiple sclerosis (MS) is a complex, devastating and enigmatic immune-mediated neurovascular
                                 disease of the central nervous system (CNS) that is characterized by inflammatory
                                 demyelination, degeneration of neurons and axonal loss. In our project we are proposing
                                 to examine endothelial particles that represent the future for analysis of blood biomarkers,
                                 as they can simultaneously provide information on several proteins originally derived
                                 from the brain cell surface. We would like to validate these biomarkers against the
                                 MRIs of the patients, which, until this time, have been the only objective and reliable
                                 diagnostic tool for MS. If our hypotheses are confirmed our project will propel the
                                 neurolymphatic biomarker matrix as a potentially new, non-invasive and inexpensive
                                 tool for diagnosis and monitoring of MS. 
